Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the ...

Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ...

Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced the winners of the ...

Quantum-Si's fundamentals are weak at the moment, and this likely extends beyond market conditions. Click here to find out ...

Pillar Biosciences, Inc., the leader in Decision Medicine(TM), announced its participation in the 2025 Association for Molecular Pathology (AMP) Annual Meeting in Boston, MA. The company and ...

On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...

India-specific database of Coronary Artery Diseases will help identify if a person has a risk factor of developing heart ...

Illumina (ILMN) just launched BioInsight, a new business unit focused on combining sequencing, software, and AI for advanced biological insights. Executive changes and this expansion highlight the ...

Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...

Single-cell transcriptome sequencing results of rats intervened with specific mode electroacupuncture (an emerging method for opening the blood-brain barrier).

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...